BSE - Delayed Quote INR

Nath Bio-Genes (India) Limited (NATHBIOGEN.BO)

Compare
192.20 -1.75 (-0.90%)
At close: December 20 at 2:52:06 PM GMT+5:30
Loading Chart for NATHBIOGEN.BO
DELL
  • Previous Close 193.95
  • Open 201.00
  • Bid 190.10 x --
  • Ask 193.20 x --
  • Day's Range 192.10 - 201.00
  • 52 Week Range 167.50 - 264.50
  • Volume 6,364
  • Avg. Volume 3,676
  • Market Cap (intraday) 3.653B
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) 9.34
  • EPS (TTM) 20.58
  • Earnings Date Jan 16, 2025 - Jan 20, 2025
  • Forward Dividend & Yield 2.00 (1.04%)
  • Ex-Dividend Date Aug 9, 2024
  • 1y Target Est --

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Mumbai, India.

nathbiogenes.com

423

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NATHBIOGEN.BO

View More

Performance Overview: NATHBIOGEN.BO

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NATHBIOGEN.BO
6.47%
S&P BSE SENSEX
8.03%

1-Year Return

NATHBIOGEN.BO
8.61%
S&P BSE SENSEX
9.25%

3-Year Return

NATHBIOGEN.BO
21.36%
S&P BSE SENSEX
36.89%

5-Year Return

NATHBIOGEN.BO
43.09%
S&P BSE SENSEX
87.27%

Compare To: NATHBIOGEN.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NATHBIOGEN.BO

View More

Valuation Measures

Annual
As of 12/20/2024
  • Market Cap

    3.65B

  • Enterprise Value

    2.99B

  • Trailing P/E

    9.34

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    0.57

  • Enterprise Value/Revenue

    0.85

  • Enterprise Value/EBITDA

    5.64

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.22%

  • Return on Assets (ttm)

    3.45%

  • Return on Equity (ttm)

    6.33%

  • Revenue (ttm)

    3.51B

  • Net Income Avi to Common (ttm)

    393.73M

  • Diluted EPS (ttm)

    20.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.77M

  • Total Debt/Equity (mrq)

    19.91%

  • Levered Free Cash Flow (ttm)

    -262.71M

Research Analysis: NATHBIOGEN.BO

View More

Company Insights: NATHBIOGEN.BO

Research Reports: NATHBIOGEN.BO

View More

People Also Watch